Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-23-014791
Filing Date
2023-11-03
Accepted
2023-11-03 21:05:10
Documents
1
Period of Report
2023-11-02

Document Format Files

Seq Description Document Type Size
1 form4-11032023_091101.html 4  
1 form4-11032023_091101.xml 4 7907
  Complete submission text file 0001415889-23-014791.txt   9292
Mailing Address 13011 MCCALLEN PASS BUILDING A SUITE 100 AUSTIN TX 78753
Business Address 13011 MCCALLEN PASS BUILDING A SUITE 100 AUSTIN TX 78753 650-249-9090
Natera, Inc. (Issuer) CIK: 0001604821 (see all company filings)

EIN.: 010894487 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8071 Services-Medical Laboratories

Mailing Address C/O NATERA, INC. 201 INDUSTRIAL ROAD, SUITE 410 SAN CARLOS CA 94070
Business Address
Sheena Jonathan (Reporting) CIK: 0001646649 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37478 | Film No.: 231377892